Approximately 30% of psoriasis (PsO) patients develop psoriatic arthritis (PsA), which can appear with mild, moderate, or severe PsO. Dermatologists are often the first health care providers to both screen and make the diagnosis.
FDA Alerts
FDA Alerts
Wednesday, October 31, 2018
The FDA has approved a new biosimilar for patients with various autoimmune diseases, including psoriasis and psoriatic arthritis.
FDA Alerts
Wednesday, June 20, 2018
The FDA has approved the inclusion of new evidence to the prescribing label for secukinumab for the treatment of psoriatic arthritis.
FDA Alerts
Tuesday, May 29, 2018
The FDA has approved expanding the indication for certolizumab pegol (Cimzia) to include adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
FDA Alerts
Wednesday, March 21, 2018
The FDA approved a new therapy for the treatment plaque psoriasis among adult patients. For administration and adverse effects, read more.
Featured
Featured
Tuesday, December 4, 2018
This case report discusses apremilast for the treatment of psoriasis in an adolescent girl with needle phobia.
Features
Features
Friday, January 18, 2019
Approximately 30% of psoriasis (PsO) patients develop psoriatic arthritis (PsA), which can appear with mild, moderate, or severe PsO. Dermatologists are often the first health care providers to both screen and make the diagnosis.
News
News
Wednesday, December 5, 2018
The American College of Rheumatology and National Psoriasis Foundation released new guidelines on the management of active psoriatic arthritis among treatment‐naïve individuals.
News
Friday, October 26, 2018
A recent poster study, presented at the 2018 Fall Clinical Dermatology Conference, examined the risk of malignancy associated with biologics among patients with psoriasis.
News
Wednesday, October 24, 2018
In a recent study, researchers assessed the efficacy of a tumor necrosis factor inhibitor combined with methotrexate at achieving remission among patients with early active psoriatic arthritis.
News
Monday, October 22, 2018
Findings from a recent study highlight the destructive nature of psoriatic arthritis and the influence of age and disease duration on anabolic and catabolic bone damage.
NPF Endorsed Articles
NPF Endorsed Articles
Thursday, January 3, 2019
A review of recent news, research, and treatment related to psoriasis.
NPF Endorsed Articles
Tuesday, August 28, 2018
A review of recent news, research, and treatment related to psoriasis.
NPF Endorsed Articles
Friday, June 22, 2018
A review of recent news, research, and treatment related to psoriasis.
NPF Endorsed Articles
Wednesday, May 16, 2018
Psoriasis is associated with comorbid disease conditions that can significantly impact the quality of life for these patients.
Quizzes
Quizzes
Tuesday, July 31, 2018
Which of the following is not a differential diagnosis of cutaneous T-cell lymphoma?
Research in Review
Research in Review
Tuesday, December 4, 2018
A review of recent news, research, and treatment related to PsA, including presentations from the 2018 American College of Rheumatology Annual Meeting.
Research in Review
Tuesday, October 30, 2018
This article focuses on the baseline risk of malignancy, risks associated with treatments for psoriasis, and management strategies for patients with psoriasis and a history of malignancy.
Research in Review
Tuesday, July 31, 2018
Recently approved therapies, drugs in development, and expanded labels for existing psoriasis drugs continue to offer clinicians and patients an expanding range of options for treatments.
Research in Review
Friday, July 27, 2018
A review of recent news, research, and treatment related to psoriasis.